Abstract Submission Deadline: September 27, 2025 - Don’t miss out – Mid Term Registration closes on September 30, 2025 - Submit your abstract and secure your spot today!
Cancer & Oncology
Cancer Treatment & Therapy
Cancer Immunotherapy
Gynecologic Oncology
Cancer Biomarkers
Haematological Malignancies
Sarcoma
Cancer Epidemiology
Cancer Survivorship
Cancer Biology
Robotic and Integrative Oncology
Artificial Intelligence in Cancer
Oncology Nursing
Blood Cancer
Cancer Nanotechnology
Organ-specific Cancers
Radiation Oncology
Surgical Oncology
Pediatric Oncology
Liquid Biopsies
Oncology Pharmacy and Drug Safety
Non-metastatic and Metastatic NSCLC
3D Bioprinting & Organoids in Cancer Modeling
Cancer Drug Market & Clinical Trials in Oncology like this more and new and latest
Cancer & Oncology
Cancer & Oncology is the field dedicated to understanding, diagnosing, and treating cancer through medical, surgical, and radiation-based approaches. It encompasses cancer biology, innovative therapies, clinical research, and patient care strategies aimed at prevention, early detection, and improving survival outcomes.
Cancer Treatment & Therapy
Cancer Treatment & Therapy focuses on the latest advances in diagnosing, managing, and treating various types of cancer. It encompasses a range of approaches including surgery, chemotherapy, radiation therapy, immunotherapy, targeted therapies, and emerging personalized medicine strategies—aimed at improving patient outcomes, reducing side effects, and enhancing quality of life.
Cancer Immunotherapy
Cancer Immunotherapy is an advanced treatment approach that harnesses the body’s immune system to recognize, target, and destroy cancer cells. This includes therapies such as immune checkpoint inhibitors, CAR T-cell therapy, cancer vaccines, and monoclonal antibodies—offering promising outcomes, especially in cancers resistant to conventional treatments.
Gynecologic Oncology
This session delves into the latest advancements in the diagnosis, treatment, and management of cancers affecting the female reproductive system, including ovarian, cervical, endometrial, vulvar, and vaginal cancers. Topics include surgical innovations, molecular profiling, targeted therapies, immunotherapy, and approaches to fertility preservation. Experts will also discuss disparities in care, early detection strategies, and quality-of-life considerations in gynecologic cancer patients.
Cancer Biomarkers
Cancer Biomarkers are biological molecules found in blood, tissues, or other body fluids that indicate the presence or progression of cancer. They play a vital role in early detection, diagnosis, prognosis, and monitoring treatment response, as well as in guiding personalized and targeted therapy approaches.
Haematological Malignancies
Haematological Malignancies are cancers that affect the blood, bone marrow, lymphatic system, and lymphoid tissues. This group includes leukemia, lymphoma, myeloma, and myelodysplastic syndromes. These cancers disrupt normal blood cell production and function, and treatment options often involve chemotherapy, stem cell transplantation, targeted therapies, and immunotherapy, depending on the type and stage of the disease.
Sarcoma
Sarcoma is a rare type of cancer that originates in the bones and soft tissues, including muscles, fat, nerves, and blood vessels. It encompasses a diverse group of tumors with distinct biological behaviors and treatment responses. Early diagnosis and specialized care are crucial for improving outcomes in sarcoma patients.
Cancer Epidemiology
Cancer Epidemiology studies the patterns, causes, and risk factors of cancer in populations. It aims to identify trends, assess the impact of environmental and genetic factors, and inform strategies for prevention, early detection, and public health interventions to reduce the global cancer burden.
Cancer Survivorship
Cancer Survivorship focuses on the health and well-being of individuals after cancer treatment, addressing the physical, emotional, psychosocial, and financial challenges survivors may face. It emphasizes long-term follow-up care, rehabilitation, monitoring for recurrence, and improving quality of life throughout and beyond the cancer journey.
Cancer Biology
Cancer Biology explores the molecular and cellular mechanisms that drive the development, progression, and spread of cancer. This field focuses on understanding genetic mutations, tumor microenvironments, signaling pathways, and the biological behavior of cancer cells, providing the foundation for developing targeted therapies and innovative treatment strategies.
Robotic and Integrative Oncology
Robotic Oncology involves the use of advanced robotic-assisted surgical systems to perform precise, minimally invasive procedures for cancer treatment. This technology enhances surgeon control, reduces recovery time, and improves surgical outcomes, especially in complex or delicate operations involving organs like the prostate, kidneys, and gynecologic structures.
Integrative Oncology combines conventional cancer treatments with evidence-based complementary therapies to support the physical, emotional, and spiritual well-being of patients. It includes approaches such as nutrition, acupuncture, mindfulness, exercise, and stress management—aimed at enhancing quality of life, reducing side effects, and empowering patient-centered care.
Artificial Intelligence in Cancer
Artificial Intelligence (AI) in Cancer is revolutionizing oncology by enhancing early detection, diagnosis, treatment planning, and personalized care. Through advanced data analysis, machine learning, and predictive modeling, AI supports radiology, pathology, genomics, and drug discovery—enabling faster, more accurate, and data-driven decisions in cancer care.
Oncology Nursing
Oncology Nursing is a specialized field focused on caring for individuals diagnosed with cancer across all stages of the disease. Oncology nurses play a vital role in administering treatments, managing symptoms and side effects, providing emotional support, and educating patients and families—ensuring compassionate, holistic, and evidence-based care.
Blood Cancer
Blood Cancer, also known as hematologic cancer, affects the blood, bone marrow, or lymphatic system. The main types include leukemia, lymphoma, and multiple myeloma. These cancers interfere with normal blood cell production and immune function, requiring specialized diagnostic and treatment approaches such as chemotherapy, immunotherapy, and stem cell transplantation.
Cancer Nanotechnology
Explore the cutting-edge intersection of nanotechnology and oncology. This session delves into the design and application of nanoscale materials for cancer diagnosis, imaging, and targeted drug delivery. Learn how nanomedicine is revolutionizing personalized cancer therapy, reducing side effects, and enhancing treatment precision. Presentations will highlight breakthroughs in nanoparticle platforms, nano-enabled biosensors, and clinical translation of nanotech innovations.
Organ-specific Cancers
Organ-specific Cancers refer to malignancies that originate in specific organs, such as the lungs, breast, prostate, liver, colon, or pancreas. Each type has distinct risk factors, symptoms, diagnostic methods, and treatment strategies. Studying these cancers individually helps in developing targeted therapies and improving patient-specific care.
Radiation Oncology
Radiation Oncology is a medical specialty that uses high-energy radiation to treat cancer by destroying or damaging cancer cells while preserving surrounding healthy tissue. It plays a critical role in curative, palliative, and adjuvant cancer care, often used alone or in combination with surgery and chemotherapy.
Surgical Oncology
Surgical Oncology is a specialized branch of oncology focused on the surgical management of cancer. It involves the removal of tumors and surrounding tissue, assessment of cancer spread, and plays a key role in diagnosis, staging, and treatment planning—often in combination with other therapies like chemotherapy and radiation.
Pediatric Oncology
Pediatric Oncology is the branch of medicine focused on the diagnosis and treatment of cancer in children, adolescents, and young adults. It addresses unique cancer types that occur in younger patients and involves specialized therapies tailored to their developmental needs, with an emphasis on improving survival rates and long-term quality of life.
Liquid Biopsies
Liquid Biopsies are non-invasive diagnostic tests that detect cancer-related biomarkers—such as circulating tumor DNA (ctDNA), cells, or exosomes—in body fluids like blood. They offer a promising tool for early cancer detection, monitoring treatment response, assessing minimal residual disease, and tracking tumor evolution in real-time.
Oncology Pharmacy and Drug Safety
This session highlights the critical role of oncology pharmacists in optimizing cancer treatment and ensuring patient safety. Topics include safe handling and administration of antineoplastic agents, managing drug interactions and toxicities, personalized dosing strategies, and pharmacovigilance in clinical oncology. Learn how advancements in pharmaceutical care and safety protocols contribute to improved treatment outcomes, reduced adverse effects, and enhanced patient-centered cancer care.
Non-metastatic and Metastatic NSCLC
Non-metastatic NSCLC refers to early-stage non-small cell lung cancer that has not spread beyond the lungs or regional lymph nodes. Treatment often involves surgery, radiation therapy, or a combination of both, potentially followed by chemotherapy or targeted therapies to prevent recurrence.
Metastatic NSCLC, on the other hand, is an advanced stage where cancer has spread to other parts of the body, such as the brain, liver, or bones. Treatment options include chemotherapy, immunotherapy, targeted therapies, and combination treatments aimed at controlling the disease and improving quality of life, though metastasis complicates treatment and prognosis.
3D Bioprinting & Organoids in Cancer Modeling
This session focuses on the transformative potential of 3D bioprinting and patient-derived organoids in replicating the complex architecture and microenvironment of human tumors. These cutting-edge models offer unprecedented insights into tumor biology, drug response, and personalized medicine. Discover how bioprinted tumor constructs and organoid systems are accelerating preclinical research, enhancing therapeutic screening, and paving the way for more predictive and ethical cancer research platforms.
Cancer Drug Market & Clinical Trials in Oncology like this more and new and latest
Cancer Drug Market & Clinical Trials in Oncology is rapidly evolving, driven by innovations in targeted therapies, immunotherapy, and precision medicine. The market for cancer drugs continues to expand with new FDA-approved treatments, particularly for previously difficult-to-treat cancers. Clinical trials play a critical role in testing novel drug combinations, investigating biomarker-driven therapies, and assessing the efficacy of cutting-edge treatments. These trials are paving the way for personalized approaches, offering hope for better outcomes and longer survival rates for patients.
Terms & Condition
Acceptance of Terms and Subsequent Amendments
By using our websites, you fully and legally accept our terms and conditions. we reserve the right to modify these Terms at any time without prior notice. The most current version of the Terms will always be accessible via the link at the bottom of the Site. Continued use of the Site following the posting of any changes constitutes your acceptance of the revised Terms. Please review the Terms periodically for any updates or modifications. If you do not agree to the terms, you are not authorized to use the site.
Conference Registration Payment Methods
Different modes of payment:
Online Mode: Payment for registration can be made separately from the respective conference websites. We have two International Payment gateways: Stripe and PayPal. Both accept payments from all types of cards credit/debit, Visa, Mastercard, and Discover credit cards. American Express cards are not accepted for payment. All the cards must have international transaction enabled. For some payments respective may ask for authorization for completion of registration. We accept in all three currencies USD, EUROs & GBP.
Encryption and Security: the online mod of registration is secured and end to end encrypted. We don’t save or share credit card personal information anywhere, ensuring secure transmission of participant data.
Wire Transfer: Wire/bank transfer can be done from any country. We accept in all three currencies USD, EUROs & GBP.
Offline Mode: This mode of payment is only applicable for cash payment at the registration desk to the conference organizers.
Refund Policies
- Cancellations made more than 60 days before the conference start date will receive a full refund, minus a $150/€150/£150 administrative fee.
- Cancellations made between 59 and 45 days prior to the conference start date will receive a 50% refund.
- Cancellations made less than 45 days before the conference start date are non-refundable.
- Refunds will be processed within 30 days of receiving the cancellation notification and request should be in writing to Conference Mail ID & finance@c2pforum.com.
- The processed refund may take up to 9-10 business days to appear in your account or statement.
- E-poster fees are non-refundable.
- Discounted registrations are nonrefundable in cash or credit.
- In case of visa refusal, the refund policies will be as per time policies or can be transferred to any substitute or any other event only once.
Cancellation Policies
- We strictly adhere to our cancellation policies, and cancellations must be made in writing. we reserve the right to change these policies without prior notice.
- The Organizer holds the sole right to cancel or postpone the conference or webinar in the event of natural disasters, calamities, terrorist activities, pandemics, or other unavoidable and unforeseeable circumstances. Attendees will be informed of any such changes by the respective program managers.
- The Organizer will not be responsible for any loss or damage resulting from the substitution, alteration, postponement, or cancellation of an event due to circumstances beyond its control, including but not limited to force majeure, natural disasters, pandemics, sabotage, accidents, trade or industrial disputes, terrorism, or hostilities.
- If the conference or webinar is cancelled or postponed due to circumstances beyond the Organizer's control, registrations will remain valid for future conferences or webinars. The paid registration and accommodation fees will be automatically carried forward to future events. Refund policies will not apply in these cases.
- If a registrant is unable to attend the rescheduled conference or webinar date, they will be eligible to receive a credit for the full amount paid, which can be used to attend any conference within 12 months.
- The Organizer accepts no liability for personal injuries or for loss or damage to delegates' property during or as a result of the conference or webinar.
Accommodation Cancellation Policies
Respective conference hotels confirm hotel reservations from the organizers only after receiving of full payment. Booked accommodations can be cancelled before 45-30 days before the Check in date. It varies from country-to-country hotel policies. Less than 45-30 days of the event, change in the check in-check out date and cancellation will not be allowed and will not be entitled for refund.
Visa Info
- We urge the attendees to apply for visa in the due course of time ASAP. Registration fees does not include the cost of visa.
- C2P Forum will not contact any embassies for the issuance of visa. We can support by providing invitation letter from organization.
- Under C2P Forum cancelation policy, C2P Forum cannot be held responsible for any participants inability to obtain visas and visa issues cannot be regarded.
Insurance and Transportation
Insurance cost is not included in the registration. Registrants are responsible for their parking and transportation. Shuttle facility to and from airport to hotel varies from hotel to hotel. We request you to obtain correct information of the hotel from conference manager or directly from hotel.
Invitation Letters
Invitation letters will be issued only to the paid registered attendees.
Substitutions and Transfers
If the registrants are unable to attend for any valid reason are eligible to substitute to another speaker or delegate at least 30 days before the event, request should be made in writing to info@c2pforum.com.
Only fully paid registration including Accommodations (in case) are eligible for transfer of their registration fee to the conference scheduled for the following year, if it falls within 12 months from the date of the affected/cancelled conference. However, the organizers reserve the right to approve or deny such transfer requests, likely to manage logistical and administrative considerations. Discounted cost paid towards accommodation are not eligible to transfer. The registrations transferred are not eligible for any reimbursement.
Photos and Filming
Filming or recording the conference presentation are not allowed due to privacy concerns from the attendees. Organizer photographer will take the snaps which will be sent to everyone once we get them after editing post 15 days of the event. Participants not interested in filming need to inform in writing to the organizers in prior.
Unsolicited Commercial E-mail (Anti-Spam) Policy
- At C2P Forum, the privacy of internet users is of paramount importance to us and our customers. We are committed to supporting the protection of client and consumer privacy rights as a fundamental aspect of our business.
- Message Recipient Policy: Clients must consent to receive emails, advertisements, or promotions from us before any such communications are sent. Any recipient may request to be removed from our mailing list at any time, and we will promptly honour such requests. Additionally, we will thoroughly investigate any allegations of unsolicited messages.
- Policy Against Unsolicited Email Advertising: We strictly require that all emails from C2p Forum are sent only to clients who have opted to receive them. We prohibit any advertising of our brand and website via unsolicited email messages. Failure to comply with this policy will result in the termination of partnerships and/or affiliate accounts.
- Unsubscribe at Any Time: Each email sent by C2p Forum will include an easy-to-use unsubscribe link, allowing recipients to remove themselves from our mailing list at any time. If you receive a newsletter or email and decide you no longer wish to receive it, simply click the unsubscribe link at the bottom of the email.
Responsibility
Attendees are sole responsible for the content you upload during the submission process. You must obtain necessary permissions from content owners and indemnify C2P for any failures in obtaining such permissions. C2p will not be responsible for ant third-party content or external links on the website. The attendee will be solely responsible for all their belongings at the venue. Whatever be the reason the organizer will not be responsible for any stolen or missing items of attendees.
Authorization
By registering for the conference, you authorize C2P Forum to capture, record, and utilize your name, likeness, image, and comments. This includes the right to publish, reproduce, exhibit, distribute, broadcast, edit, and/or digitize these materials in publications, advertising materials, or any other form, worldwide, without compensation. Please note that photographing and/or videotaping during any session is strictly prohibited. For any queries, please contact us.
Miscellaneous
Heading in the terms and conditions are given for the convenience of readers. It is highly advisable to readd all the terms and conditions before proceeding as it is completer responsibility of the reader only. For any specific queries or clarification, it is advised to contact the conference manager and C2P directly.